NCT01684605View on ClinicalTrials.gov

Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 12, 2012

Primary Completion Date

November 13, 2012

Study Completion Date

January 3, 2013

Conditions
Anemia
Interventions
DRUG

NESP 60μg

Administrated NESP 60μg once intravenously

DRUG

CKD-11101 60μg

Administrated CKD-11101 60μg once intravenously

Trial Locations (1)

Unknown

Seoul national university hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT01684605 - Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers | Biotech Hunter | Biotech Hunter